GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Phio Pharmaceuticals Corp (FRA:44R3) » Definitions » Float Percentage Of Total Shares Outstanding

Phio Pharmaceuticals (FRA:44R3) Float Percentage Of Total Shares Outstanding : 99.83% (As of Jun. 17, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Phio Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Phio Pharmaceuticals's float shares is 4.56 Mil. Phio Pharmaceuticals's total shares outstanding is 4.57 Mil. Phio Pharmaceuticals's float percentage of total shares outstanding is 99.83%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Phio Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Phio Pharmaceuticals's Institutional Ownership is 0.76%.

Phio Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Phio Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=4.56/4.57
=99.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phio Pharmaceuticals (FRA:44R3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Phio Pharmaceuticals Corp (FRA:44R3) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
SLRX PXMD SNPX RVLPQ NVIV THAR IVBT HSTC SCNI ATNF OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
PHIO:USA
Address
257 Simarano Drive, Suite 101, Marlborough, MA, USA, 01752
Website
https://www.phiopharma.com
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.

Phio Pharmaceuticals (FRA:44R3) Headlines

No Headlines